-
first such insulin,
Humulin, but did not
commercially market the
product themselves. Eli
Lilly marketed Humulin in 1982.
Humulin was the
first medication...
-
Humulin R
Regular U-500 (Concentrated)
insulin human injection, USP (rDNA Origin) is a
stronger concentration (500 units/mL) of
Humulin R.
Humulin 70/30...
- and Hans
Christian Hagedorn (an
insulin researcher).Brand
names include Humulin N,
Novolin N,
Novolin NPH,
Gensulin N,
SciLin N, Insulatard, and NPH Iletin...
-
pharmaceutical companies to
produce human insulin using recombinant DNA
including Humulin (insulin medication),
Humalog (insulin lispro), and the
first approved...
-
engineered human insulin in 1978. The
insulin produced by bacteria,
branded Humulin, was
approved for
release by the Food and Drug
Administration in 1982....
-
pharmacodynamic equivalence of Biocon's
biosimilar Insulin‐R with the US ‐licensed
Humulin® R
formulation in
healthy subjects:
Results from the
RHINE ‐1 (Recombinant...
-
Examples of short-acting
insulins (peak 2–4 hours) are:
Regular insulin (
Humulin R,
Novolin R)
Prompt insulin zinc (Semilente)
Examples of intermediate-acting...
-
using Humulin "N" or NPH
insulin for cats,
which is very fast-acting for most cats. The slower-acting
Lente and
Ultralente (
Humulin L and
Humulin U) insulins...
- via
recombinant DNA.
Sometimes referred to as rHI,
under the
trade name
Humulin, was
developed by Genentech, but
licensed to Eli
Lilly and Company, who...
-
commercially available biosynthetic human insulin under the
brand name
Humulin. The vast
majority of
insulin used
worldwide is
biosynthetic recombinant...
